Logo image of PED

PEDEVCO CORP (PED) Stock Fundamental Analysis

NYSEARCA:PED - NYSE Arca - US70532Y3036 - Common Stock - Currency: USD

0.5447  -0.02 (-2.73%)

After market: 0.5589 +0.01 (+2.61%)

Fundamental Rating

5

Overall PED gets a fundamental rating of 5 out of 10. We evaluated PED against 212 industry peers in the Oil, Gas & Consumable Fuels industry. PED has only an average score on both its financial health and profitability. PED has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
In the past year PED had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PED reported negative net income in multiple years.
In the past 5 years PED always reported a positive cash flow from operatings.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With an excellent Return On Assets value of 13.29%, PED belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
With a decent Return On Equity value of 14.69%, PED is doing good in the industry, outperforming 66.98% of the companies in the same industry.
PED has a worse Return On Invested Capital (2.98%) than 69.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PED is significantly below the industry average of 25.75%.
Industry RankSector Rank
ROA 13.29%
ROE 14.69%
ROIC 2.98%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

PED's Profit Margin of 44.98% is amongst the best of the industry. PED outperforms 91.98% of its industry peers.
PED's Operating Margin of 12.12% is in line compared to the rest of the industry. PED outperforms 40.57% of its industry peers.
With a decent Gross Margin value of 68.53%, PED is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PED has grown nicely.
Industry RankSector Rank
OM 12.12%
PM (TTM) 44.98%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PED is destroying value.
PED has more shares outstanding than it did 1 year ago.
PED has more shares outstanding than it did 5 years ago.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PED has an Altman-Z score of 1.77. This is a bad value and indicates that PED is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PED (1.77) is better than 63.68% of its industry peers.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACC0.29
WACC10.27%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PED has a Current Ratio of 1.91. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
PED's Current ratio of 1.91 is fine compared to the rest of the industry. PED outperforms 75.47% of its industry peers.
A Quick Ratio of 1.91 indicates that PED should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.91, PED is doing good in the industry, outperforming 76.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

PED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 185.71%, which is quite impressive.
PED shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.49%.
The Revenue has been growing by 24.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%376.79%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%56.87%

3.2 Future

The Earnings Per Share is expected to decrease by -36.44% on average over the next years. This is quite bad
Based on estimates for the next years, PED will show a decrease in Revenue. The Revenue will decrease by -0.26% on average per year.
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.72, the valuation of PED can be described as very cheap.
PED's Price/Earnings ratio is rather cheap when compared to the industry. PED is cheaper than 96.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.88, PED is valued rather cheaply.
The Price/Forward Earnings ratio is 8.99, which indicates a very decent valuation of PED.
Based on the Price/Forward Earnings ratio, PED is valued a bit cheaper than the industry average as 68.87% of the companies are valued more expensively.
PED's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.20.
Industry RankSector Rank
PE 2.72
Fwd PE 8.99
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

91.51% of the companies in the same industry are more expensive than PED, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.26
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PED's earnings are expected to decrease with -36.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (4/30/2025, 5:05:00 PM)

After market: 0.5589 +0.01 (+2.61%)

0.5447

-0.02 (-2.73%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-19 2025-05-19
Inst Owners2.95%
Inst Owner Change0%
Ins Owners73.01%
Ins Owner Change4.62%
Market Cap49.75M
Analysts80
Price Target1.86 (241.47%)
Short Float %0.2%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)692.2%
Min EPS beat(2)104.85%
Max EPS beat(2)1279.56%
EPS beat(4)3
Avg EPS beat(4)348.7%
Min EPS beat(4)-0.99%
Max EPS beat(4)1279.56%
EPS beat(8)3
Avg EPS beat(8)155.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.92%
Min Revenue beat(2)1.14%
Max Revenue beat(2)12.69%
Revenue beat(4)4
Avg Revenue beat(4)13.78%
Min Revenue beat(4)1.14%
Max Revenue beat(4)23.63%
Revenue beat(8)6
Avg Revenue beat(8)7.68%
Revenue beat(12)8
Avg Revenue beat(12)5.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.39%
PT rev (3m)1.39%
EPS NQ rev (1m)50%
EPS NQ rev (3m)50%
EPS NY rev (1m)38.47%
EPS NY rev (3m)-24.05%
Revenue NQ rev (1m)-2.15%
Revenue NQ rev (3m)-4.21%
Revenue NY rev (1m)-9.15%
Revenue NY rev (3m)-9.15%
Valuation
Industry RankSector Rank
PE 2.72
Fwd PE 8.99
P/S 1.26
P/FCF N/A
P/OCF 3.9
P/B 0.41
P/tB 0.41
EV/EBITDA 2.26
EPS(TTM)0.2
EY36.72%
EPS(NY)0.06
Fwd EY11.13%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.14
OCFY25.66%
SpS0.43
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.29%
ROE 14.69%
ROCE 3.78%
ROIC 2.98%
ROICexc 3.08%
ROICexgc 3.08%
OM 12.12%
PM (TTM) 44.98%
GM 68.53%
FCFM N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)3.72%
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 174.84%
Cap/Sales 70.86%
Interest Coverage 250
Cash Conversion 61.31%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 1.77
F-Score7
WACC10.27%
ROIC/WACC0.29
Cap/Depr(3y)201.19%
Cap/Depr(5y)159.31%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%376.79%
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.49%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%56.87%
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year208.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.63%
OCF growth 3Y28.83%
OCF growth 5Y50.2%